Company Filing History:
Years Active: 2024
Title: Luwei Han: Innovator in Antibody Drug Development
Introduction
Luwei Han is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of antibody drugs, particularly with his innovative work on anti-CD47 antibodies. His research focuses on developing pharmaceutical compositions that exhibit remarkable antitumor activity.
Latest Patents
Luwei Han holds a patent for an "Anti-CD47 antibody and application thereof." This patent relates to an anti-CD47 antibody or an antigen-binding fragment, which has shown significant antitumor activity and high affinity with the human CD47 protein. The invention aims to eliminate the capability of SIRPa to bind to CD47 on the surface of cells, while also ensuring minimal hemoagglutination activity. This makes it a promising candidate for the preparation of anti-tumor drugs.
Career Highlights
Luwei Han is associated with Nanjing Sanhome Pharmaceutical Co., Ltd., where he continues to advance his research in antibody drug development. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.
Collaborations
Luwei Han collaborates with notable colleagues, including Yong Wang and Liwen Zhao. Their combined expertise contributes to the innovative research and development of new therapeutic solutions.
Conclusion
Luwei Han's contributions to the field of antibody drugs, particularly through his patent on anti-CD47 antibodies, highlight his role as an influential inventor in the pharmaceutical industry. His work promises to pave the way for new treatments in cancer therapy.